Why we don’t (not really) think properly about risk in drug development 3 Mar Written by Johnathan Lowery Patient Safety, Regulatory Compliance and Well-Formulated Studies are “the job” and have already been priced in. Coming Soon Johnathan Lowery Previous Previous Quantifying the value of investment in innovation for clinical development Next Next Drug development is not like software development (and why this matters)
Why we don’t (not really) think properly about risk in drug development 3 Mar Written by Johnathan Lowery Patient Safety, Regulatory Compliance and Well-Formulated Studies are “the job” and have already been priced in. Coming Soon Johnathan Lowery
